Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Proteinuria × Bevacizumab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 8 Breast Neoplasms 5 Neoplasms 3 Neoplasm Metastasis 3 Ovarian Neoplasms 2 Liver Neoplasms 2 Colonic Neoplasms 2 Solid Tumor 1 Proteinuria 1 Peritoneal Neoplasms 1 Non-Squamous Non-Small Cell Lung Cancer 1 Locally Advanced Colorectal Cancer 1 Fallopian Tube Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

anlotinib 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07358520 2026-01-22

Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients

Fudan University

Phase 4 Not yet recruiting

Proteinuria

Data powered by HemOnc (CC BY 4.0) Colophon ⚡